Regulatory Rapporteur May 2011
Volume 8 Issue 5
In This Issue
- The true value of regulatory intelligence – and how to apply it to strategic eff ect
- PLUS
- A unique view of EMA–FDA collaboration
- Disharmony in the medical devices arena?
Please login to download articles. Non-members may download the Focus article.
| Title | Download | Category | Size | File |
|---|---|---|---|---|
| Regulatory Rapporteur May 2011 | Members | Full Issue | 2MB | |
| Fostering collaboration between regulatory agencies | Public | 512KB | ||
| Sharing regulatory intelligence: Are newsletters here to stay or is social media the future? | Public | 502KB | ||
| An EFPIA view of the consultation process on proposed guidelines | Members | 484KB | ||
| EU regulatory updates during March 2011 | Members | 471KB | ||
| The evolution of regulatory intelligence from a regional affiliate office perspective | Members | 480KB | ||
| The evolution of the regulatory intelligence paradigm | Members | 470KB | ||
| The impact of regulatory intelligence in the wider pharmaceutical business and demonstrating its value | Members | 567KB | ||
| The Medical Devices Exchange | Members | 539KB | ||
| Unravelling the EU consultation period: A quick guide to draft guidance consultation processes | Members | 480KB |
